Abnormal Uterine Bleeding Linked to Fatigue in Menopause Transition
FRIDAY, March 14, 2025 -- Prolonged (PMB) or heavy (HMB) menstrual bleeding during the menopause transition (MT) is associated with experiencing certain symptoms of fatigue, according to a study published online March 11 in Menopause.
Siobán D. Harlow, Ph.D., from the University of Michigan in Ann Arbor, and colleagues identified episodes of PMB or HMB using longitudinal daily menstrual calendar data from 2,329 participants in the Study of Women's Health Across the Nation. Four symptoms of fatigue (worn out, feeling tired, full of pep, having energy) were queried at seven annual follow-up visits. The association between each fatigue variable and PMB or HMB recorded during the previous six months was examined.
The researchers found that reporting three or more episodes of HMB in the previous six months was positively associated with feeling tired and being worn out after adjustment (odds ratios [95 percent confidence intervals], 1.62 [1.11 to 2.38] and 1.44 [0.98 to 2.13], respectively), while there was a negative association seen for three or more episodes of PMB in the previous six months with being full of pep (odds ratio, 0.68; 95 percent confidence interval, 0.49 to 0.95).
"This study highlights the need for greater clinical awareness of abnormal uterine bleeding, particularly given the increased frequency during the menopause transition and its association with low energy or fatigue symptoms," Stephanie Faubion, M.D., medical director of The Menopause Society, said in a statement. "Educating women about the possibility of prolonged or heavy menstrual bleeding during the menopause transition and the potential health consequences is also needed."
One author disclosed past financial ties to CVS.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Elinzanetant Safe, Effective for Moderate-to-Severe Vasomotor Symptoms
TUESDAY, Sept. 30, 2025 -- Elinzanetant, a dual neurokinin-targeted therapy, is effective for treating menopause-associated moderate-to-severe vasomotor symptoms (VMS), according...
Older Adults Can Regain Well-Being
THURSDAY, Sept. 25, 2025 -- Older adults can regain well-being, according to a study published online Sept. 24 in PLOS ONE. Mabel Ho, Ph.D., and Esme Fuller-Thomson, Ph.D...
Wrist Cooling May Help Manage Vasomotor Symptoms
WEDNESDAY, Sept. 24, 2025 -- Targeted wrist cooling may offer a safe approach for managing vasomotor symptoms, according to a study published online Sept. 20 in Endocrinology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.